Regulatory Affairs Services

Process Standardization

We address these challenges through end-to-end process standardization services tailored to U.S. FDA, EMA, Health Canada, PMDA, and ICH expectations. Whether you're preparing for your first IND or managing a portfolio of global submissions, we help streamline operations from SOP creation to automation-enabled dossier workflows.

Overview

In today’s fast-paced regulatory environment, life sciences companies must not only achieve compliance but sustain it across multiple products, regions, and functional teams. The lack of standardized processes often leads to inconsistent documentation, longer review cycles, and increased regulatory risk.

At Techsol, we address these challenges through end-to-end process standardization services tailored to U.S. FDA, EMA, Health Canada, PMDA, and ICH expectations. Whether you’re preparing for your first IND or managing a portfolio of global submissions, we help streamline operations from SOP creation to automation-enabled dossier workflows.

Process Standardization Consulting services:

Techsol has deep domain experience in regulatory process standardization across the key functional areas to drive consistency, compliance, and cross-functional synergy. We provide consulting services to Sponsors and research organizations on the following services on the Process Standardization.

  • Standardized eCTD publishing workflows
  • Dossier compilation procedures
  • Health authority response management protocols
  • SOPs for site activation, monitoring, and close-out
  • Serious Adverse Event (SAE) reporting workflows
  • Clinical and safety data reconciliation processes
  • QMS documentation templates and versioning
  • Deviation and CAPA management procedures
  • Audit trail capture and oversight mechanisms
  • Harmonized batch record documentation
  • Control strategy implementation workflows
  • Change control and notification procedures
  • Label version control and tracking
  • Regulatory compliance checks
  • CCDS (Company Core Data Sheet) harmonization

Techsol has established a standard, and fully validated clinical and non-clinical templates which are acceptable by Regulatory authorities.

  • Clinical Reports
  • Clinical Overviews
  • Clinical Summaries
  • Integrated Clinical Reports
  • Non Clinical Reports
  • Non-Clinical Summaries
  • Non- Clinical Overviews

Our Expertise:

At Techsol, our deep industry experience and hands-on execution have enabled life sciences clients to standardize and streamline regulatory processes with precision. Our proven capabilities include:

We have successfully designed and implemented modular, audit-ready Standard Operating Procedures (SOPs) across diverse regulatory functions—including submissions, labeling, change control, and HA correspondence. These SOPs are tailored to product complexity and regional compliance expectations (ICH, USFDA, EMA, etc.).

Our team has developed validated, submission-ready templates and QA checklists for INDs, NDAs, BLAs, MAAs, DMFs, and labeling documents. These tools have accelerated submission preparation cycles while ensuring consistency, traceability, and completeness across teams.

We’ve integrated automation-ready workflows for eCTD publishing, version control, and submission tracking in real-world projects. This has enabled regulatory teams to reduce manual interventions, maintain control over content versions, and meet tight submission deadlines.

From USPI and CCDS to SmPC, SPL, and mock-ups, Techsol has built end-to-end labeling frameworks that support global harmonization. We’ve helped clients synchronize regional updates and minimize non-compliance risks during safety-driven labeling changes.

Techsol has supported multiple post-approval variation workflows by deploying structured SOPs, risk assessment matrices, and change control tools—enabling clients to manage global product changes effectively while maintaining continuous compliance.

Through cross-functional collaboration and standardization, we’ve helped clients establish harmonized regulatory practices across the U.S., EU, Canada, and APAC. Our frameworks are scalable across product types and therapeutic areas, supporting efficient multi-region submissions and lifecycle updates.

Our Value Proposition

  • Trusted partner supporting U.S., EU, APAC, LATAM, and MENA regulatory operations.
  • Led by Techsol SMEs with former roles at US FDA, EMA, and key international regulatory bodies.
  • Fully aligned with ICH, US FDA, EMA, Health Canada, PMDA, MHRA, TGA, LATAM, and MENA regulatory frameworks.
  • Ensures audit-ready submissions and robust global regulatory strategy.
  • Expertise spanning IND/IMPD, NDA/BLA/MAA submissions, and post-approval variations.
  • Supports faster time-to-market with smooth interactions across multiple health authorities.
  • Tailored frameworks for emerging biotech, mid-size pharma, and large global enterprises.
  • Adapts to varying regulatory complexities and submission volumes.
  • Leverages proven SOPs, templates, and checklists from successful real-world submissions.
  • Reduces manual effort, minimizes rework, and accelerates submission readiness.

Regulatory Affairs Services

RIMS

Regulatory Strategy

regulatory-intelligence

Regulatory Intelligence

hand-touching-digital-screen-with-data-visualization_23-2151964669

Regulatory Submissions

standard-quality-control-concept-m_23-2150041850

Gene Therapy Products

futuristic-business-scene-with-ultra-modern-ambiance_23-2151003762

Labeling and Artwork

workers-long-wooden-table_1262-810

HA Interactions & Country Support

businesspeople-exchanging-ideas_1098-3622

Regulatory QMS & Audit Support

group-people-working-out-business-plan-office_1303-15859

Pre-Submission Meetings: IND

medium-shot-team-sitting-table_23-2149271747

Pre-Submission Meetings: NDA

business-team-watching-discussing-presentation-laptop-male-executive-pointing-display_74855-7987

Pre-Submission Meetings: BLA

Latest Relevant Case Studies

Clinical-Study-Protocols-960x600-1

May 1, 2025

Specialized Regulatory Writing Solutions for Clinical Overviews in Combination Therapy Submissions

Media (3)

April 29, 2025

Developing a complex clinical trial Protocol for a CNS-based Psychiatric product …

June 10, 2025

Case study on regulatory strategy development and dossier submission support

Media (2)

June 10, 2025

Case study on medical device product registration in india

Latest Relevant Insights

Medical Device Registrations | Techsol Life Sciences

July 12, 2023

Mastering Medical Device Registrations: A Guide to Navigating Regulatory Pathways

Regulatory Compliance

June 21, 2021

Evolution in Global Pharmaceutical Regulatory Landscape & Notable Changes for Sponsors

Regulatory Consulting

June 5, 2021

Emerging Trends in Regulatory Affairs by Adapting to Latest Technological Advancements

MoCRA Cosmetics Regulatory Compliance FDA Techsol Life Sciences

Kanuary 29, 202

MoCRA Made Easy: A Comprehensive Guide to Cosmetic Safety Compliance

Edit Template

Request a Demo